CELULARITY IMPACT Trademark

Trademark Overview


On Monday, February 14, 2022, a trademark application was filed for CELULARITY IMPACT with the United States Patent and Trademark Office. The USPTO has given the CELULARITY IMPACT trademark a serial number of 97265928. The federal status of this trademark filing is REGISTERED as of Tuesday, July 5, 2022. This trademark is owned by Celularity Inc.. The CELULARITY IMPACT trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Manufacturing services of biopharmaceuticals and gene and cell therapy products, namely, genetically engineered tissues for others; manufacturing services for others in the fields of mammalian cell banks, plasmids, purified mitochondria, cell lysates; production of cells for others; custom manufacturing of cells for others; advanced cell manufacturing for others; manufacturing process consulting

Research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; laboratory research services in the field of genomics, biotechnology and pharmaceuticals consisting of collection, testing, processing, preservation, storage and retrieval of bioengineered cells, human allograft tissue made from human umbilical cords and human placentas, human amniotic membrane and human chorionic membrane, human collagen and extracellular matrix compositions; providing a website featuring information in the field of medical research relating to banking stem cells and cord blood banking; biosourcing of clinically accessible, immune-tolerant human stem and progenitor and other postpartum placenta-derived cell populations and tissues for medical research; scientific and tech...
celularity impact

General Information


Serial Number97265928
Word MarkCELULARITY IMPACT
Filing DateMonday, February 14, 2022
Status700 - REGISTERED
Status DateTuesday, July 5, 2022
Registration Number6782541
Registration DateTuesday, July 5, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 19, 2022

Trademark Statements


Goods and ServicesManufacturing services of biopharmaceuticals and gene and cell therapy products, namely, genetically engineered tissues for others; manufacturing services for others in the fields of mammalian cell banks, plasmids, purified mitochondria, cell lysates; production of cells for others; custom manufacturing of cells for others; advanced cell manufacturing for others; manufacturing process consulting
Goods and ServicesResearch, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; laboratory research services in the field of genomics, biotechnology and pharmaceuticals consisting of collection, testing, processing, preservation, storage and retrieval of bioengineered cells, human allograft tissue made from human umbilical cords and human placentas, human amniotic membrane and human chorionic membrane, human collagen and extracellular matrix compositions; providing a website featuring information in the field of medical research relating to banking stem cells and cord blood banking; biosourcing of clinically accessible, immune-tolerant human stem and progenitor and other postpartum placenta-derived cell populations and tissues for medical research; scientific and technological services, namely, scientific research, analysis, and testing in the field of genomics, biotechnology, and pharmaceuticals; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing; research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, February 18, 2022
Primary Code040
First Use Anywhere DateFriday, March 29, 2019
First Use In Commerce DateFriday, March 29, 2019

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 18, 2022
Primary Code042
First Use Anywhere DateFriday, March 29, 2019
First Use In Commerce DateFriday, March 29, 2019

Trademark Owner History


Party NameCelularity Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFlorham Park, NJ 07932

Party NameCelularity Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFlorham Park, NJ 07932

Party NameCelularity Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFlorham Park, NJ 07932

Trademark Events


Event DateEvent Description
Tuesday, July 5, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 5, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, April 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 19, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 15, 2022ASSIGNED TO LIE
Friday, March 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 11, 2022EXAMINER'S AMENDMENT ENTERED
Friday, March 11, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 11, 2022EXAMINERS AMENDMENT E-MAILED
Friday, March 11, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 1, 2022ASSIGNED TO EXAMINER
Friday, February 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 17, 2022NEW APPLICATION ENTERED IN TRAM